S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 G1 TherapeuticsCollegium PharmaceuticalProvention BioKadmonVanda Pharmaceuticals
SymbolNASDAQ:GTHXNASDAQ:COLLNASDAQ:PRVBNASDAQ:KDMNNASDAQ:VNDA
Price Information
Current Price$22.10$23.59$12.72$4.59$18.65
52 Week RangeBuyHoldBuyBuyHold
MarketRank™
Overall Score1.51.41.42.01.4
Analysis Score3.51.23.53.51.0
Community Score2.42.52.64.02.7
Dividend Score0.00.00.00.00.0
Ownership Score1.70.00.81.71.7
Earnings & Valuation Score0.03.10.00.61.9
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyHold
Consensus Price Target$49.17$25.00$30.75$14.00$15.40
% Upside from Price Target122.47% upside5.98% upside141.75% upside205.01% upside-17.43% downside
Trade Information
Market Cap$840.82 million$815.79 million$718.53 million$787.25 million$1.02 billion
Beta2.441.273.341.680.56
Average Volume1,759,138773,2801,126,0413,990,948606,319
Sales & Book Value
Annual RevenueN/A$296.70 millionN/A$5.09 million$227.19 million
Price / SalesN/A2.75N/A154.664.51
CashflowN/AN/AN/AN/A$2.88 per share
Price / CashN/AN/AN/AN/A6.47
Book Value$6.80 per share$2.61 per share$1.72 per share$0.95 per share$7.70 per share
Price / BookN/A9.04N/A4.832.42
Profitability
Net Income$-122,450,000.00$-22,720,000.00$-43,280,000.00$-61,370,000.00$115.55 million
EPS($3.27)($0.68)($1.06)($0.74)$2.11
Trailing P/E RatioN/A48.14N/AN/A51.81
Forward P/E RatioN/A14.30N/AN/A33.91
P/E GrowthN/A0.73N/AN/AN/A
Net MarginsN/A5.71%N/A-768.36%8.02%
Return on Equity (ROE)-49.35%12.64%-67.66%-85.07%4.56%
Return on Assets (ROA)-41.53%3.15%-62.27%-46.46%3.88%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.10%1.27%N/A0.02%N/A
Current Ratio7.45%1.08%9.23%5.76%6.35%
Quick Ratio7.45%1.01%9.23%5.76%6.33%
Ownership Information
Institutional Ownership Percentage77.89%N/A39.42%94.78%97.64%
Insider Ownership Percentage14.49%8.08%14.40%2.95%5.90%
Miscellaneous
Employees10425519115284
Shares Outstanding38.05 million34.58 million56.49 million171.51 million54.88 million
Next Earnings Date5/5/2021 (Estimated)5/6/2021 (Estimated)5/6/2021 (Estimated)3/4/2021 (Estimated)5/5/2021 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.